Unani approach to graded management of thrombosis in Covid-19 patients

IF 0.6 Q4 INTEGRATIVE & COMPLEMENTARY MEDICINE Current Traditional Medicine Pub Date : 2023-09-14 DOI:10.2174/2215083810666230914103404

Zikra Tahseen. A, Ghulamuddin Sofi, Arisha Shahid, None Sofia, Shahila Aazam

{"title":"Unani approach to graded management of thrombosis in Covid-19 patients","authors":"Zikra Tahseen. A, Ghulamuddin Sofi, Arisha Shahid, None Sofia, Shahila Aazam","doi":"10.2174/2215083810666230914103404","DOIUrl":null,"url":null,"abstract":"Background and objectives: This study aimed to explore the treatment of thrombosis caused by Covid-19 with the drugs used in Unani medicine. Unani medicine has rich literature that mentions the pathogenesis, causes, and treatment of the diseases caused by obstruction of vessels. The study explores various drugs with actions that complement the resulting thrombolytic actions and details the rational treatment plan following the Unani medicine protocol. Methodology: The literature regarding thrombosis was surveyed from indexed online journals. The concept of thrombosis in Unani literature was surveyed from the source texts of Unani medicine. The treatment strategy and drugs with anti-thrombotic actions were explored, and a rational graded management of thrombosis in Covid-19 patients was presented that forms the general treatment plan of Unani medicine in patients with thrombosis. Results: The study observed that several Unani drugs from natural sources are mentioned for de-obstruent action. De-obstruent action is a composite action that encompasses anti-inflammatory, disintegratory, blood detoxification, and other activities. There was a concordance with the concept of thrombolytic action, as mentioned in conventional medicine. When rationally used, these drugs form a graded treatment of thrombosis associated with Covid-19. Conclusion: There is a potentially successful treatment plan with several de-obstruent drugs in Unani medicine that may be explored to treat thrombosis associated with Covid-19.","PeriodicalId":11026,"journal":{"name":"Current Traditional Medicine","volume":"31 1","pages":"0"},"PeriodicalIF":0.6000,"publicationDate":"2023-09-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current Traditional Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2174/2215083810666230914103404","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"INTEGRATIVE & COMPLEMENTARY MEDICINE","Score":null,"Total":0}

引用次数: 0

Abstract

Background and objectives: This study aimed to explore the treatment of thrombosis caused by Covid-19 with the drugs used in Unani medicine. Unani medicine has rich literature that mentions the pathogenesis, causes, and treatment of the diseases caused by obstruction of vessels. The study explores various drugs with actions that complement the resulting thrombolytic actions and details the rational treatment plan following the Unani medicine protocol. Methodology: The literature regarding thrombosis was surveyed from indexed online journals. The concept of thrombosis in Unani literature was surveyed from the source texts of Unani medicine. The treatment strategy and drugs with anti-thrombotic actions were explored, and a rational graded management of thrombosis in Covid-19 patients was presented that forms the general treatment plan of Unani medicine in patients with thrombosis. Results: The study observed that several Unani drugs from natural sources are mentioned for de-obstruent action. De-obstruent action is a composite action that encompasses anti-inflammatory, disintegratory, blood detoxification, and other activities. There was a concordance with the concept of thrombolytic action, as mentioned in conventional medicine. When rationally used, these drugs form a graded treatment of thrombosis associated with Covid-19. Conclusion: There is a potentially successful treatment plan with several de-obstruent drugs in Unani medicine that may be explored to treat thrombosis associated with Covid-19.

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

新冠肺炎患者血栓形成分级管理方法

背景与目的:本研究旨在探讨应用Unani药物治疗新型冠状病毒感染的血栓形成。乌纳尼医学文献丰富，对血管梗阻病的病机、病因、治疗等方面都有论述。本研究探讨了各种具有补充溶栓作用的药物，并详细说明了遵循Unani药物方案的合理治疗计划。方法:从有索引的在线期刊中调查有关血栓形成的文献。从乌纳尼医学源文献入手，对乌纳尼文献中血栓概念进行了考察。探讨治疗策略及具有抗血栓作用的药物，提出Covid-19患者血栓形成的合理分级管理，形成Unani药物对血栓形成患者的总体治疗方案。结果:几种天然来源的乌纳尼类药物均有疏通作用。疏通作用是一种复合作用，包括抗炎、分解、血液解毒和其他活动。这与传统医学中提到的溶栓作用的概念是一致的。如果合理使用，这些药物可形成与Covid-19相关的血栓形成的分级治疗。结论:在乌纳尼药物中有一种可能成功的治疗方案，可以探索治疗新冠肺炎相关血栓形成。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Current Traditional Medicine INTEGRATIVE & COMPLEMENTARY MEDICINE-

CiteScore

1.40

自引率

0.00%

发文量

期刊介绍： Current Traditional Medicine covers all the aspects of the modernization and standardization research on traditional medicine of the world, e.g. chemistry, pharmacology, molecular mechanism, systems biology, proteomics, genomics, metabolomics, safety, quality control, clinical studies of traditional Chinese, Ayurvedic, Unani, Arabic and other ethnomedicine. Each issue contains updated comprehensive in-depth/mini reviews along with high quality original experimental research articles. Current Traditional Medicine is a leading and important international peer-reviewed journal reflecting the current outstanding scientific research progresses of the global traditional, indigenous, folk and ethnologic medicine. It provides a bridge connected the tradition medicine system to the modern life science with the efforts of top scientists, as well as a resource to pursuit the solutions for the existing common issues in the traditional medicine.